Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

FDA Alerts

Enzyme Replacement Therapy
Enzyme Replacement Therapy
First Enzyme Replacement Therapy to Treat Rare Genetic Disorder Approved
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
Enzyme Replacement Therapy
Enzyme Replacement Therapy
First Enzyme Replacement Therapy to Treat Rare Genetic Disorder Approved
03/17/2023
Jessica Ganga
Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.
03/17/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA alert
FDA
FDA alert
FDA Approves First Oral Treatment for CKD-Caused Anemia for Adults on Dialysis
02/08/2023
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
02/08/2023
FDA ALERTS
FDA ALERTS
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023
FDA ALERTS
FDA ALERTS
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
01/27/2023